These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2148949)

  • 1. Interaction of Fusobacterium nucleatum 191 with human peripheral blood lymphocytes.
    Tuttle RS; Mangan DF
    J Periodontal Res; 1990 Nov; 25(6):364-71. PubMed ID: 2148949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-lectin-like mechanism by which Fusobacterium nucleatum 10953 adheres to and activates human lymphocytes.
    Tuttle RS; Strubel NA; Mourad J; Mangan DF
    Oral Microbiol Immunol; 1992 Apr; 7(2):78-83. PubMed ID: 1528636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of coaggregation between Fusobacterium nucleatum and Porphyromonas (Bacteroides) gingivalis by lactose and related sugars.
    Kolenbrander PE; Andersen RN
    Infect Immun; 1989 Oct; 57(10):3204-9. PubMed ID: 2777379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectinlike interactions of Fusobacterium nucleatum with human neutrophils.
    Mangan DF; Novak MJ; Vora SA; Mourad J; Kriger PS
    Infect Immun; 1989 Nov; 57(11):3601-11. PubMed ID: 2553609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of coaggregation between Bacteroides gingivalis T22 and Fusobacterium nucleatum T18.
    Kinder SA; Holt SC
    Infect Immun; 1989 Nov; 57(11):3425-33. PubMed ID: 2478473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attachment of Fusobacterium nucleatum PK1594 to mammalian cells and its coaggregation with periodontopathogenic bacteria are mediated by the same galactose-binding adhesin.
    Weiss EI; Shaniztki B; Dotan M; Ganeshkumar N; Kolenbrander PE; Metzger Z
    Oral Microbiol Immunol; 2000 Dec; 15(6):371-7. PubMed ID: 11154434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
    Metzger Z; Blasbalg J; Dotan M; Weiss EI
    J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of multimodal co-aggregation between Fusobacterium nucleatum and streptococci.
    Takemoto T; Hino T; Yoshida M; Nakanishi K; Shirakawa M; Okamoto H
    J Periodontal Res; 1995 Jul; 30(4):252-7. PubMed ID: 7562321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding specificity of Fusobacterium nucleatum to human erythrocytes, polymorphonuclear leukocytes, fibroblasts, and HeLa cells.
    Ozaki M; Miyake Y; Shirakawa M; Takemoto T; Okamoto H; Suginaka H
    J Periodontal Res; 1990 May; 25(3):129-34. PubMed ID: 2141873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a galactose-binding lectin on Fusobacterium nucleatum FN-2.
    Murray PA; Kern DG; Winkler JR
    Infect Immun; 1988 May; 56(5):1314-9. PubMed ID: 2451642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells.
    Edwards AM; Grossman TJ; Rudney JD
    Infect Immun; 2006 Jan; 74(1):654-62. PubMed ID: 16369022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte suppression of Fusobacterium nucleatum-induced human polyclonal B-lymphocyte activation.
    Mangan DF; Won T; Lopatin DE
    Infect Immun; 1984 Nov; 46(2):332-9. PubMed ID: 6334029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonspecific induction of immunoglobulin M antibodies to periodontal disease-associated microorganisms after polyclonal human B-lymphocyte activation by Fusobacterium nucleatum.
    Mangan DF; Won T; Lopatin DE
    Infect Immun; 1983 Sep; 41(3):1038-45. PubMed ID: 6604024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugar inhibition of oral Fusobacterium nucleatum haemagglutination and cell binding.
    Mongiello JR; Falkler WA
    Arch Oral Biol; 1979; 24(7):539-45. PubMed ID: 44185
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of specific sugars to inhibit bacterial adherence to equine endometrium in vitro.
    King SS; Young DA; Nequin LG; Carnevale EM
    Am J Vet Res; 2000 Apr; 61(4):446-9. PubMed ID: 10772112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells.
    Bachrach G; Ianculovici C; Naor R; Weiss EI
    FEMS Microbiol Lett; 2005 Jul; 248(2):235-40. PubMed ID: 15993010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coinfection with Fusobacterium nucleatum can enhance the attachment and invasion of Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans to human gingival epithelial cells.
    Li Y; Guo H; Wang X; Lu Y; Yang C; Yang P
    Arch Oral Biol; 2015 Sep; 60(9):1387-93. PubMed ID: 26143497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human peripheral blood lymphocytes by Fusobacterium nucleatum.
    Shenker BJ; DiRienzo JM
    J Immunol; 1984 May; 132(5):2357-62. PubMed ID: 6715883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum enters normal human oral fibroblasts in vitro.
    Dabija-Wolter G; Cimpan MR; Costea DE; Johannessen AC; Sørnes S; Neppelberg E; Al-Haroni M; Skaug N; Bakken V
    J Periodontol; 2009 Jul; 80(7):1174-83. PubMed ID: 19563299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different responses in B cells induced by Porphyromonas gingivalis and Fusobacterium nucleatum.
    Gemmell E; Seymour GJ
    Arch Oral Biol; 1992; 37(7):565-73. PubMed ID: 1359860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.